financetom
Business
financetom
/
Business
/
Exxon Mobil expects fourth-quarter upstream earnings to ease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exxon Mobil expects fourth-quarter upstream earnings to ease
Jan 7, 2025 2:10 PM

Exxon Mobil ( XOM ) said on Tuesday changes in oil prices would ease its fourth-quarter upstream earnings by $500 million to $900 million.

The industry bellwether had posted $6.16 billion in upstream earnings for the third quarter, and a net profit of $7.63 billion in the year-ago fourth quarter.

(Reporting by Tanay Dhumal and Vallari Srivastava in Bengaluru; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apogee Therapeutics Prices Upsized $420 Million Share Offering
Apogee Therapeutics Prices Upsized $420 Million Share Offering
Mar 8, 2024
05:14 AM EST, 03/08/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) said late Thursday it priced an upsized underwritten public offering of about 6.8 million shares at $62 apiece, targeting gross proceeds of $420 million. The company said the offering will likely close on March 12. Apogee, which is offering all of the shares in the sale, has granted...
China's Xpeng's drone car AeroHT Voyager X2 completes low-altitude flight in Guangzhou city
China's Xpeng's drone car AeroHT Voyager X2 completes low-altitude flight in Guangzhou city
Mar 8, 2024
BEIJING (Reuters) - Chinese EV maker Xpeng's affiliate, XPENG AEROHT, said on Friday its flying drone car AeroHT Voyager X2 completed a low-altitude flight in the central business district of the southern city of Guangzhou, the company said in a statement. ...
Kyverna Therapeutics Teams Up With Stanford University to Evaluate Investigational Multiple Sclerosis Drug
Kyverna Therapeutics Teams Up With Stanford University to Evaluate Investigational Multiple Sclerosis Drug
Mar 8, 2024
05:20 AM EST, 03/08/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said late Thursday it has formed a collaboration with Stanford University to allow the use the of the company's KYV-101 investigational therapy for multiple sclerosis in a phase 1 investigator-initiated trial. The trial will evaluate the safety, tolerability, and clinical activity of the drug in up to 12...
BYD spearheads Chinese electric car push in Australia, a friendlier market
BYD spearheads Chinese electric car push in Australia, a friendlier market
Mar 8, 2024
(This March 5 story has been corrected to attribute a prediction to BMI, a unit of Fitch Group, and not Fitch Ratings, in paragraph 25) By Stella Qiu SYDNEY (Reuters) - BYD and other Chinese automakers are bringing new electric car models in droves to Australia, a market where they haven't faced trade barriers and sales have surged due to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved